APA (7th ed.) Citation

Cano-Calderón, J. M., Zazueta-Pozos, J. F., Gallardo-Rodríguez, A. G., Martínez-Murillo, C., Olarte-Carrillo, I., Martínez-Tovar, A., & Ramos-Peñafiel, C. O. Bortezomib, thalidomide, and dexamethasone versus thalidomide and dexamethasone for response rates in multiple myeloma patients: A retrospective study. Permanyer.

Chicago Style (17th ed.) Citation

Cano-Calderón, Juan M., Juan F. Zazueta-Pozos, Adán G. Gallardo-Rodríguez, Carlos Martínez-Murillo, Irma Olarte-Carrillo, Adolfo Martínez-Tovar, and Christian O. Ramos-Peñafiel. Bortezomib, Thalidomide, and Dexamethasone Versus Thalidomide and Dexamethasone for Response Rates in Multiple Myeloma Patients: A Retrospective Study. Permanyer.

MLA (9th ed.) Citation

Cano-Calderón, Juan M., et al. Bortezomib, Thalidomide, and Dexamethasone Versus Thalidomide and Dexamethasone for Response Rates in Multiple Myeloma Patients: A Retrospective Study. Permanyer.